The kidneys in inflammatory bowel disease

Annals of Gastroenterology

Volumn 15, Issue 1, 2002, Pages 41-52

  Katsanos, K H ^a   Tsianos, E V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Crohn's; Drugs; Genital; Glomerular; Inflammatory bowel disease; Interstitial; Kidneys; Renal; Therapy; Tubular; Ulcerative colitis; Urinary

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ALPHA 1 MICROGLOBULIN; AMINOSALICYLIC ACID DERIVATIVE; AZATHIOPRINE; BETA 2 MICROGLOBULIN; CEFUROXIME AXETIL; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DIPEPTIDYL PEPTIDASE IV; GAMMA GLUTAMYLTRANSFERASE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODOHIPPURATE SODIUM I 131; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METRONIDAZOLE; MICROSOMAL AMINOPEPTIDASE; N ACETYL BETA GLUCOSAMINIDASE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OLSALAZINE; OXALIC ACID; PENTETATE INDIUM IN 111; SALAZOSULFAPYRIDINE; SODIUM DIHYDROGEN PHOSPHATE; TRANSFERRIN; UNINDEXED DRUG; XYLITOL;

ACUTE KIDNEY FAILURE; AMYLOIDOSIS; AUTOPSY; BLADDER FISTULA; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE DURATION; DISEASE SEVERITY; DRUG FATALITY; ELECTRON MICROSCOPY; ENTERITIS; GENITAL SYSTEM DISEASE; GLOMERULONEPHRITIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HYPEROXALURIA; IMMUNOHISTOCHEMISTRY; INTERSTITIAL NEPHRITIS; INTESTINE SURGERY; KIDNEY BIOPSY; KIDNEY CANCER; KIDNEY CORTEX NECROSIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; LOW DRUG DOSE; MICROSCOPY; MICTURITION CYSTOURETHROGRAPHY; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROLITHIASIS; NEPHROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PYELOGRAPHY; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RENOVASCULAR HYPERTENSION; REVIEW; SEXUAL DYSFUNCTION; TERATOGENICITY; ULCERATIVE COLITIS; URETER INJURY; URETER OBSTRUCTION; URINARY TRACT DISEASE; URINE RETENTION; URODYNAMICS; UROGENITAL TRACT CANCER;

EID: 33644914765     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Allan RN, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams J, Fazio VW (eds). Inflammatory bowel disease (3d edition) Churchill Livingstone New York, 1997.
2. Pardi DS, Tremain WJ, Sandborn WJ, Mc Carthy JT. Renal and urologic complications of inflammatory bowel disease. Am Journ Gastroenterol 1998; 93:504-514.
3. Wilcox GM, Aretz TH, Roy MA, Roche JK. Glomerulonephritis associated with inflammatory bowel disease. Gastroenterology 1990; 98:786-791.
4. Kreisel W, Wolf LM, Grotz W, Grieshaber A Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:461-468
5. Fitchen JH. Amyloidosis and granulomatous ileocolitis. NEJM 1970; 295:352-353.
6. Steigmann F. Urinary tract complications in regional enteritis. Am Journ Gastroenterol, 1973; 59:389-396
7. Shield DE, Lytton D, Weiss RM, et al. Urologic complications of inflammatory bowel disease. J Urol 1976; 115:701-706.
8. Nakajima H, Munakata A, Yoshida Y. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985; 56:2314-2321.
9. Ekbom A, Helmick C, Zack M, Adami HO. Extracolonic malignancies in inflammatory bowel disease. Cancer 1991; 67:2015-2019.
10. Rosa M, Caglioti A, Mazza G, et al. Does the presence of ANCA in patients with ulcerative colitis necessarily imply renal involvement? Nephrol Dial Transplant 1996; 11:2426-2429.
11. Savige JA, Chang L, Wilson D, Buchanan RR. Autoantibodies and target antigens in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Rheumatol Int 1996; 16:109-114.
12. Skogh T, Heuman R, Tagesson C. Anti-brush border antibodies (ABBA) in Crohn's disease. J Clin Lab Immunol 1982; 9:147-150.
13. Rabin BS, Rogers S. Pathologic changes in the liver and kidney produced by immunization with intestinal antigens. Am J Pathol 1976; 84:201-210.
14. Rugtveit J, Scott H, Halstensen TS, Norstein J, Brandt Zaeg P. Expression of the L1 antigen (calprotectin) by tissue macrophages reflects recent recruitment from peripheral blood rather than upregulation of local synthesis:implications for rejection diagnosis in formalin-fixed kidney speciments. J Pathol 1996; 180:194-199.
15. Weiss DJ, Gagne JM, Armstrong PJ. Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis and nephritis in cats. J Am Vet Med Assoc 1996; 209:1114-1116.
16. Hauser CJ, Locke RR, Kao HW, Patterson J, Zipser RD. Visceral surface oxygen tension in experimental colitis in the rabbit. J Lab Clin Med 1988; 112:68-71.
17. Guller R, Reichlin B, Jost G. Colonic preparation with sodium phosphate. Prospective, randomized, placebo-controlled double blind study with various antiemetics. Schweiz Med Wochenschr 1996; 126:1352-1357.
18. Sandle GI. Salt and water absorption in the human colon: a modern appraisal. Gut 1998; 43:294-299.
19. Yamada H, Kotaki H, Sawzda Y, Iga T. Mechanism of the uricosuric action of the anti-inflammatory drug E34010 used to treat inflammatory bowel disease I: Study using a rat model of hyperuricemia. Biopharm Drug Dispos 1999; 20:77-83.
20. Ikebe M, Miyakawa K, Takahashi K, et al. Lymphoaematopoietic abnormalities and systemic lymphoproliferative disorder in interleukin-2 receptor gamma chain-deficient mice. Int J Exp Pathol 1997; 78:133-148
21. Witte T., Olbricht C, Koch KM. Interstitial nephritis associated with 5-aminosalicylic acid. Nephron 1994; 67:481-482.
22. Courey RW, Pfister RC. The radiopraphic findings in renal tubular acidosis. Radiology; 1972 (Dec); 497-503.
23. Victorino RM, Lucas MB, de Moura MC. Severe osteomalakia associated with renal tubular acidosis in Crohn's disease. Dig Dis Sci 1986; 31:322-326.
24. Roddie ME, Peters AM, Danpure HJ, et al. Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. Radiology 1988; 166:767-772.
25. Brynskov J, Thomsen H, Nielsen SL. Renographic monitoring of renal function in patients with Crohn's disease treated with low Vose cyclosporin: a controlled study. Br Med J 1990; 300:1438-1439.
26. Presti ME, Neuschwander-Terti BA, Vogler CA, Janney CG, Roche JK. Sclerosing cholangitis, inflammatory bowel disease and glomerulonephritis. Dig Vis Sci 1997; 42:813-816.
27. Vilela MP, Borges DR, Carvalho JC.Nonspecific ulcerative retrocolitis with lupus Orythematosus.Presentation of a case. Press Med 1971; 7:1060-1061
28. Peeters AJ., Van den Wall Bake WL, Daha MR, Breedveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Reum Dis 1990; 49:638-640.
29. Riley SA, Lloyd DR, Mani V. Tests of renal function in patients with quiescent colitis: effects of drug treatment. Gut 1992; 33:1348-1352.
30. Komorowski RA, Cohen EP, Kaffman HM, Adams MB. Gastrointestinal complications in renal transplant recipients. Am J Clin Pathol 19$6; 86:161-167.
31. Fausa O, Nygaard K, Elgio K. Amyloidosis and Crohn's disease. Scand J Gastroentorol 1977; 12:657-662.
32. Williams JD, Salaman JR, Griffin PJA, Hillis AN, Ross W, Williams GT. Malabsorption of cyclosporin in renal transplant recipient with Crohn's disease (letter). Lancet 1987:914-915.
33. Salvatierra O Jr, Longaker M, Crombleholme T. Bilateral renal autotransplantation with pyelovesicostomy: a surgical treatment of refracto enteric hyperoxaluria. Surgery 1089; 105:430-435.
34. Marangella M, Vitale C, Petrarulo M, Cosseddu D, Gallo L, Linari F. Pathogenesis of severe hyperoxalaemia in Crohn's disease-related renal failure on maintenance haemodialysis: successful management with pyridoxine. Nephrol Dial Transplant 1992; 7:960-964.
35. Muro K, Kobayashi M, Shimizu Y, et al. A case of systemic AA amyloidosis complicating Crohn's disease. Nippon Jinco Gakkai Shi 1998; 40:284-289.
36. Mc Callum D, Smith L, Harley F, Yiu Y. IgA nephropathy and thin basement membrane disease in asociation with Crohn disease. Pediatr Nephrol 1997; 11:637-640.
37. Dabadie A, Gie S, Tague S, Babut JM, Roussey M. Glomerular nephropathy with IgA mesangium deposots and Crohn disease. Arch Pediatr 1996; 3:884-887.
38. Koutras A, Daum F, Das KM, et al. Sulfasalazine and renal tubular function: lack of an effect. J Pediatr Gastroenterol Nutr 1985; 4:103-106
39. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Ped Gastroenterol Nutr 1994; 19:7-21.
40. Kezaki N, Nakano T, Kiyama S, et al. A case of secondary amyloidosis complicated with ulcerative colitis. Nippon Giunzo Gakkai Shi 1990; 32:435-439.
41. Chan A, Depew W, Vanner S. Use of oral sodium phosphate colonic lavage solution by Canandian colonoscopists: pitfalls and complications. Can J Gastroenterol 1997; 11:334-338.
42. Nightingale JMD, Lennard-Jone JE, Gerten DJ, Wood SR, Bartram CI. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 1992; 33:1493-1497.
43. Talamini MA, Broe PJ, Cameron LJ. Urinary fistulas in Crohn's disease. Surg Gyn Ob 1982; 154:553-556.
44. Fazio VW, Jones LT, Jagelman DG. Rectourethral fistulas in Crohn's disease. Surg Gyn Ob 1987; 164:148-150.
45. Sagar PM, Dozios RR, Wolff BG. Long-term results of ileal pouch-anal anastomosis in patients with Crohn's disease. Dis Colon Rectum 1996; 39:893-898.
46. Newman NM, Correy JF. Possible teratogenecity of sulfasalazine. Med J Aust 1983; 1:528-529.
47. Boddie DE, Couper GW, Keenan RA. Hydronephrosis: unrecognized complication following restorative proctocolectomy with ileal pouch-anal anastomosis. World J Surg 1999; 23:104-106.
48. Cristie PM, Knight GS, Hill GI.Comparison of relative risks of urinary stone formation after surgery for ulcerative colitis: conventional ileostomy vs J-pouch. A comparative study. Dis Col Rectum 1996; 39:50-54.
49. Christl SU, Scheppach W. Metabolic consequences of total colectomy Scand J Gastroenterol suppl. 1997; 222:20-24.
50. Enker WE, Block GE. Occult destructive uropathy complicating Crohn's disease. Arch Surg 1970; 101: 319-326.
51. Satsangi J, Marshall J, Roskell D, Jewell D. Ulcerative colitis complicated by renal cell carcinoma: a series of three patients. Gut 1996; 38:148-150.
52. Clarke AM, Mc Kenzie RG. Ileostomy and the risk of urinary uric acid stones. Lancet 1969; 2:395-401.
53. Paris J, Delacroix R, Dupont A, Paris JC. Right pyelic dilatation by ureteral compression during an ileocolic localisation of Crohn's disease. Acta Gastroenterol Belg 1969; 32:645-651.
54. Christie PM, Knight GS, Hill GL. Comparison of relative risk of urinary stone formation after surgery for ulcerative colitis. Conventional ileostomy j-pouch. A comparative study. Dis Colon Rectum 1996; 39:50-54.
55. Hylander E, Jarnum S, Jensen HJ, Thale M. Enteric hyperoxaluria: dependence on small intestinal resection, colectomy and steatorrhoea in chronic inflammatory bowel disease. Scand J Gastroenterol 1978; 13:577-588.
56. Admirand WH Earnest DL, Johnson G, Williams HE,. Hyperoxaluria in patients with ileal resection: An abnormality in dietary oxalate absorption. Gastroenterology 1974; 66:1114-1122.
57. Ludwig B, Schindler E, Bohl J, Pfeiffer J, Kremer G. Reno-cerebral oxalosis induced by xylitol. Neuroradiology 1984; 26:517-521:
58. Mandel I, Krauss E, Millan JC.Oxalate-induced acute renal failure in Crohn's disease. Am Journ Med 1980; 69:628-632.
59. Trivino A, Sanches Lombrana JL, Linares A, Perez R, Herrero Zapatero A, Rodrigo L. Ulcerative colitis and amyloidosis. Presentation of a case and review of the literature. Rev Esp Enferm Dig 1992; 82(2):117-120.
60. Vernon SE. Amyloid colitis. Dis Colon Rectum 1982; 25:728-30
61. Gitkind MJ, Wright SC. Amyloidosis complicating inflammatory bowel disease. Dig Dis Sci 1990; 35:906-908.
62. Gilat T, Revach M, Sohar E. Deposition of amyloid in the gastrointestinal tract. Gut 1969; 10:98-104.
63. Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel distase. Dis Colon Rectum 1986; 29:351-354
64. Husby G.Amyloidosis.Semin Arthr Rheum 1992; 22:67-82DZD
65. Edwards P, Cooper DA, Turner J, O'Connor TJ, Byrnes DJ. Resolution of amyloidosis (AA type) complicating chronic ulcerative colitis. Gastroenterology 1988; 95:810-815.
66. Fitchen JH. Amyloidosis and granoulomatous ileocolitis. Reagression after surgical removal of the involved bowel. N Engl J Med 1975; 292:352-353.
67. Meyers S, Janowitz HD, Gumaste VV, et al. Colchicine therapy of the renal amyloidosis of ulcerative colitis. Gastroenterology 1988;, 94:1503-1507.
68. Steinholf J, Schutz E, Herbst EW, Friche L, Sack K. Therapy of amyloid nephrosis in Crohn disease: plasmapheresis plus azathioprine? Wien Med Wochenschr 1988 Feb 15; 138:49-54.
69. Manley HJ, Bailie GR, Elisle G. Bilateral renal cortical necrosis associated with cefuroxime axetil. Clinical Nephrology 1988; 49:268-270.
70. Dwarakanath AD, Michael J, Allan RN. Sulfasalazine induced renal failure. Gut 1992; 33:1006-1007.
71. Willoughby CP, Aranson J, Agback H, Bodin NO, True-love SC. Distribution and Metabolism in healthy volunteers of disodium azodisalicylate a potential therapeutic agent for ulcerative colitis. Put 1982; 23:1081-1087.
72. Stokke KT, Teisberg PA, Myhre E, Hovig T, Flatmark A, Gjone E. Nephrotic syndrome in ulcerative colitis. Scand J Gastroenterol 1976; 11:571-576.
73. Svartz N. Sulfasalazine:II. Some notes on the discovery and development of salazopyrin. Am J Gastroenterol, 1988; 83:497-503
74. Wilcox GM, Reynolds JR, Galvanek EG.Nephrotoxicity associated with olsalazine. Am J Med 1996; 100:238-240
75. Schreiber S, Hamling J, Zehntez E, Howaldt S., Daerr W., Readler A, et al. Renal tubular dysfunction in patients with aminosalicylate. Gut 1997; 40:761-766.
76. World MJ, Stevens PE, Ashton MA, Rainford DJ. Mesalazine-associated interstitial nephritis. Nephrol Dial Transplant 11996; 11:614-621.
77. Calvino J, Romero R, Pintos E, Losada E, Novoa D, Guimil D, et al. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease. Clinical Nephrology 1998; 49:265-267.
78. Bonnet J, Lemman M, Prunat A,. Renal function in patients with inflammatory bowel disease on long term mesalamine or olsalazine. Gastroenterology 1995; 108: A 786 (abstract).
79. Barbour VM, Williams PF. Nephrotic Syndrome associated with sulfasalazine. Br Med J 1990; 301:818.
80. Hanauer SB, Verst-Brasch C, Regali G. Renal safety of long-term mesalamine therapy in inflammatory bowel disease. Gastroenterology 1997; 112:A 991.
81. Hawling J, Readler A, Helmchen U, Schreiber S. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion 1997; 58:304-307.
82. Klotz U. Clinical pharmacokinetics of sulfasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid. Clin Pharmacokinet 1985; 10:285-302.
83. Colombel JF,Brabant G, Gubler.MC, Locquet L, Comes MC, Dehennault M, et al Renal insufficiency in infant: side effect of prenatal exposure to mesalazine. Lancet 1994; 344:620-621.
84. Thuluvath PJ, et al. Mesalazine induced interstitial nephritis. Gut 1994; 35(10):1493-1496.
85. Crotty B., Hoang P., Dalton HR., Jewell DP. Salicylates used in inflammatory bowel disease and colchine impair interferon-γ induced HLA-DR expression. Gut 1992; 33:59-64
86. Karamanolis DG, Papatheodoridis GV, Xourgias V. Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine. Eur J Gastroenterol Hepatol 1996; 11:1083-1088
87. Clive DM, Stoff JS. Renal syndromes associated with non-steroidal anti-inflammatory drugs. N Engl J Med 1984; 310:563-572.
88. Feagan BG, Mc Donald JWD, Rochon J, Lapacis A, Fedorak RN, Kinnear D, et al. Low-dose cyclosporine for the treatment of Crohn's disease. N Engl J Med 1994; 330:1846-1851.
89. Lichtinger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med ~994; 330:1841-1845.
90. Brynskov J. Cyclosporin for inflammatory bowel disease: mechanisms and possible actions. Scand J Gastroenterol 1993; 28:849-857.
91. Kammerer J, Genin I, Michel P, Gassman-Csme H. Glomerulonephritis caused by mesangial deposits of immunoglobulins A associated with Crohn disease. Gastrenterol Clin Biol 1994; 18:293.
92. Hirsch DJ, Jindal KK, Trillo A, Cohen AD. Acute renal failure in Crohn's disease due to IgA nephropathy. Am Journ Kid Dis 1992; 20:189-190.
93. Kullman F, Kullman M, Leser HG, Kramer BK, Riegger AJ, Scholmerich J. Nephrotic syndrome as the initial symptom of Crohn's disease J Gastroenterol 1996; 34:757-762.
94. Wilcox GM, Aretz HT, Roy MA, Roche JK. Glomerulonephritis associated with inflammatory bowel disease. Gastroenterology 1990; 98:186-731.
95. Waiker A.M., Szneke P., Bianchi L.A., Field L.G., Sutherland L.R., Dreyer N.A. 5-Aminosalicylates, sulfasalazine, steroid use and complications in patients with ulcerative colitis. Am J Gastroenterol 1997; 92:816-820
96. Archimandritis AS, Weetch MS. Kidney granuloma in Crohn's disease. BMJ 1993; 307:540-541.
97. Nand N, Ward MK, Morley AR. Nephrotic syndrome in ulcerative colitis (letter). Nephrol Dial Transplant 1991; 6:227
98. Hubert D, Beufilis M, Meyrier A. Immunoglobulin A glomerular nephropathy associated with inflammatory colitis. A prepos of 2 cases. Press Med 1984; 13:1083-1085.
99. Mayyedi P. Mesangiocopillary glomerulonephritis associated with ulcerative colitis: case reports of two patients. Nephrol Dial Transplant 1995; 10:1923-1924.
100. Renyi-Vamos F, Bukky B, Balogh F. Frequency of asymptomatic significant bacteriuria in bile duct and colon inflammations. J Urol Nephron 1980; 73:439-442.